Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice-Reference-Cited by-同舟云学术

Safety and Efficacy of Second-Generation Everolimus-Eluting Xience V Stents Versus Zotarolimus-Eluting Resolute Stents in Real-World Practice

Published:2013-02 Issue:5 Volume:61 Page:536-544
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Park Kyung Woo,Lee Joo Myung,Kang Si-Hyuck,Ahn Hyo-Suk,Yang Han-Mo,Lee Hae-Young,Kang Hyun-Jae,Koo Bon-Kwon,Cho Janghyun,Gwon Hyeon-Cheol,Lee Sung Yoon,Chae In-Ho,Youn Tae-Jin,Chae Jei Keon,Han Kyoo-Rok,Yu Cheol Woong,Kim Hyo-Soo

Funder

Innovative Research Institute for Cell Therapy, Seoul National University Hospital

Medtronic

Abbot Vascular

Boston Scientific

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference20 articles.

1. Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies;Kirtane;Circulation,2009

2. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents;Serruys;N Engl J Med,2010

3. Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial;Silber;Lancet,2011

4. A randomized controlled trial in second-generation Zotarolimus-eluting resolute stents versus Everolimus-eluting Xience V stents in real-world patients: the TWENTE Trial;von Birgelen;J Am Coll Cardiol,2012

5. Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial;Park;J Am Coll Cardiol,2011

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Testing a Cloud-Based Model for Active Surveillance of Medical Devices with Analyses of Coronary Stent Safety Using the Data Extraction and Longitudinal Trend Analysis (DELTA) System;Medical Devices: Evidence and Research;2024-02

2. The Newer-Generation DES, Really Nothing to Special?;Korean Circulation Journal;2024

3. A novel biodegradable polymer-coated sirolimus-eluting stent: 1-year results of the HELIOS registry;Chinese Medical Journal;2023-06-09

4. Primary percutaneous coronary intervention in CAD patients: A comparison of major adverse cardiovascular events of second- and third-generation drug-eluting stents;Frontiers in Pharmacology;2022-11-16

5. Multi-institutional distributed data networks for real-world evidence about medical devices: building unique device identifiers into longitudinal data (BUILD);JAMIA OPEN;2022